Visitors Now:
Total Visits:
Total Stories:
Profile image
By ProactiveInvestors (Reporter)
Contributor profile | More stories
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

VolitionRX prices share offer at US$5 a pop

Friday, September 30, 2016 6:25
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Cancer diagnostics group VolitionRx Ltd (NYSEMKT:VNRX) said its previously-announced share offer has been priced at US$5 a share.

The life sciences company is set to raise around US$11.25mln through the underwritten public offer.

Volition intends to use the net proceeds of the offering for continued product development, clinical studies, product commercialization, working capital, and for other general corporate purposes.

Shares in Volition currently trade at around US$5.55 a share in New York.

Story by ProactiveInvestors

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.